Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Tools & Technology » PCR » Genetic Signatures Launches Analyte-Specific Reagents in US; Eyes FDA Approval for MDx Panels

Genetic Signatures Launches Analyte-Specific Reagents in US; Eyes FDA Approval for MDx Panels

Jul 08, 2016
|
Madeleine Johnson
Premium

NEW YORK (GenomeWeb) – Australian molecular diagnostics manufacturer Genetic Signatures recently launched a line of analyte-specific reagents in the US and collaborated with the University of California, Los Angeles to evaluate a multiplex panel assay for enteric protozoan infections with an eye toward regulatory approval and the US diagnostics market.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Fetal Tissue Research Restrictions Reversed

The Associated Press reports US officials are removing restrictions on fetal tissue research that were added during the Trump Administration.

Funds for Viral Genomic Surveillance

The Biden Administration is investing $1.7 billion to detect and monitor SARS-CoV-2 variants.

Italy Seeks to Manufacture Vaccines

Italy has held talks with vaccine developers to manufacture mRNA-based SARS-CoV-2 vaccines, according to the Financial Times.

PLOS Papers on Aicardi-Goutières Syndrome, COVID-19 in Colombian Amazon, Cancer MicroRNAs

In PLOS this week: genome instability in Aicardi-Goutières Syndrome, introduction of SARS-CoV-2 to the Colombian Amazon, and more.

Apr
29
Featured Webinar

A New Generation of PCR: At-home Testing and Preparing for Emerging Strains of COVID-19

Sponsored by
Co-Diagnostics

Join Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Labs (CRL), as she provides some insights regarding the future applications of PCR testing.

May
12
Featured Webinar

SARS-CoV-2 RNAemia Predicts Clinical Deterioration and Extrapulmonary Complications from COVID-19

Sponsored by
Combinati

This webinar will discuss a recent study that characterized the relationships between SARS-CoV-2 RNAemia and disease severity, clinical deterioration, and extrapulmonary complications (EPCs).

May
18
Featured Webinar

Put Your Money Where Your Mouth Is: Tracking and Attacking COVID-19 through State-Wide Saliva Surveillance

Sponsored by
Bio-Rad

This webinar will present the details of a COVID-19 saliva screening program that has been implemented at more than 90 different colleges, universities, private schools, and nursing homes across New York state.  

Jun
18
Featured Webinar

Disparities in Precision Oncology: Identifying Barriers and Moving Toward Solutions

Sponsored by
Canexia Health

Last year, by Precision Oncology News' count, the FDA approved 27 precision oncology drugs, a 35 percent increase in the number of approvals from 2019. 

What's Popular?

In PCR

  1. LGC Biosearch Technologies Gets FDA Emergency Use Authorization for SARS-CoV-2 Test

  2. OncoDiag Taking Aim at Broader Adoption of Molecular Multiplex Test for Bladder Cancer Recurrence

    Premium

  3. Scope Fluidics Gets CE Mark for Rapid MRSA MDx Panel

  4. With Luminex Acquisition, DiaSorin to Broaden MDx Portfolio, Expand US Presence

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.